Beat Gloor
Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.
Adamina M, Warlaumont M, Berger M, Däster S, Delaloye R, Digklia A, Gloor B, Fritsch R, Koeberle D, Koessler T, Lehmann K, Müller P, Peterli R, Ris F, Steffen T, Weisshaupt C, Hübner M. Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin. Cancers (Basel) 2022; 14
Sep 1, 2022Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.
Sep 1, 2022Cancers (Basel) 2022; 14
Adamina Michel, Warlaumont Maxime, Berger Martin D, Däster Silvio, Delaloye Raphaël, Digklia Antonia, Gloor Beat, Fritsch Ralph, Koeberle Dieter, Koessler Thibaud, Lehmann Kuno, Müller Phaedra, Peterli Ralph, Ris Frédéric, Steffen Thomas, Weisshaupt Christian, Hübner Martin
Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08)
von Holzen U, Függer R, Königsrainer A, Gloor B, Furrer M, Gerard M, Hawle H, Walz M, Alesina P, Schäfer M, Marti W, Kettelhack C, Schmidt S, Hayoz S, Steffen T, Grieder F, Bartsch D, Schnider A, Knoefel W, Piessen G, Ruhstaller T. Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08). Ann Surg 2020
Aug 26, 2020Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08)
Aug 26, 2020Ann Surg 2020
von Holzen Urs, Függer Reinhold, Königsrainer Alfred, Gloor Beat, Furrer Markus, Gerard Marie-Aline, Hawle Hanne, Walz Martin K, Alesina Piero, Schäfer Markus, Marti Walter R, Kettelhack Christoph, Schmidt Sven, Hayoz Stefanie, Steffen Thomas, Grieder Felix, Bartsch Detlef, Schnider Annelies, Knoefel Wolfram-Trudo, Piessen Guillaume, Ruhstaller Thomas
Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield
Warschkow R, Blazer D, Müller S, Gloor B, Nussbaum D, Schmied B, Erdem S, Köhn N, Tsai C, Worni M. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield. Langenbecks Arch Surg 2020; 405:43-54.
Feb 10, 2020Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer-a distinct view on lymph node yield
Feb 10, 2020Langenbecks Arch Surg 2020; 405:43-54
Warschkow Rene, Blazer Dan, Müller Sascha A, Gloor Beat, Nussbaum Daniel P, Schmied Bruno, Erdem Suna, Köhn Nastassja, Tsai Catherine, Worni Mathias
Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB
Erdem S, Worni M, Hartwig M, Blazer D, Stettler C, Schmied B, Yerokun B, Tsai C, Warschkow R, Troxler E, Gloor B. Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB. Ann Surg Oncol 2019
Oct 11, 2019Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB
Oct 11, 2019Ann Surg Oncol 2019
Erdem Suna, Worni Mathias, Hartwig Matthew, Blazer Dan G, Stettler Christoph, Schmied Bruno, Yerokun Babatunde, Tsai Catherine, Warschkow Rene, Troxler Esther, Gloor Beat
No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database
Tsai C, Mueller A, Maubach J, Warschkow R, Nussbaum D, Schmied B, Blazer D, Gloor B, Worni M. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database. Dig Surg 2019; 37:249-257.
Jul 24, 2019No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database
Jul 24, 2019Dig Surg 2019; 37:249-257
Tsai Catherine, Mueller Alexandra, Maubach Johannes, Warschkow Rene, Nussbaum Daniel P, Schmied Bruno, Blazer Dan, Gloor Beat, Worni Mathias
Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey
Steffen T, Ris F, Schmidt J, Peterli R, Adamina M, Kettelhack C, Lehmann K, Gloor B, Hübner M, Putora P, Glatzer M. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey. Clin Colorectal Cancer 2019; 18:e335-e342.
Jun 26, 2019Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey
Jun 26, 2019Clin Colorectal Cancer 2019; 18:e335-e342
Steffen Thomas, Ris Frédéric, Schmidt Jan, Peterli Ralph, Adamina Michel, Kettelhack Christoph, Lehmann Kuno, Gloor Beat, Hübner Martin, Putora Paul Martin, Glatzer Markus
High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis
Köhn N, Blazer D, Schmied B, Gloor B, Candinas D, Nussbaum D, Tsai C, Warschkow R, Maubach J, Worni M. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford) 2018; 20:1073-1081.
Jun 8, 2018High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis
Jun 8, 2018HPB (Oxford) 2018; 20:1073-1081
Köhn Nastassja, Blazer Dan G, Schmied Bruno, Gloor Beat, Candinas Daniel, Nussbaum Daniel P, Tsai Catherine, Warschkow Rene, Maubach Johannes, Worni Mathias
Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer
Steffen T, Ruhstaller T, Brauchli P, Thierstein S, Schiesser M, Gloor B, Furrer M, Marti W, Huber O, Kettelhack C, Schnider A, Dietrich D, Swiss Group for Clinical Cancer Research (SAKK). Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer. Ann Surg 2017; 269:83-87.
Jul 24, 2017Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer
Jul 24, 2017Ann Surg 2017; 269:83-87
Steffen Thomas, Ruhstaller Thomas, Brauchli Peter, Thierstein Sandra, Schiesser Marc, Gloor Beat, Furrer Markus, Marti Walter R, Huber Olivier, Kettelhack Christoph, Schnider Annelies, Dietrich Daniel, Swiss Group for Clinical Cancer Research (SAKK)
Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population
Warschkow R, Baechtold M, Leung K, Schmied B, Nussbaum D, Gloor B, Blazer Iii D, Worni M. Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population. Gastric Cancer 2017
Jun 23, 2017Selective survival advantage associated with primary tumor resection for metastatic gastric cancer in a Western population
Jun 23, 2017Gastric Cancer 2017
Warschkow Rene, Baechtold Matthias, Leung Kenneth, Schmied Bruno, Nussbaum Daniel P, Gloor Beat, Blazer Iii Dan G, Worni Mathias
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Lutz M, Maisonneuve P, Mayerle J, Martignoni M, Neoptolemos J, Rhim A, Schmied B, Seufferlein T, Werner J, van Laethem J, Lordick F, Laurent-Puig P, Huguet F, Zalcberg J, Ducreux M, Aust D, Bruno M, Büchler M, Delpero J, Gloor B, Glynne-Jones R, Hartwig W, Otto F. 3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer. Eur J Cancer 2017; 79:41-49.
Apr 29, 20173rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Apr 29, 2017Eur J Cancer 2017; 79:41-49
Lutz Manfred P, Maisonneuve Patrick, Mayerle Julia, Martignoni Marc, Neoptolemos John, Rhim Andrew D, Schmied Bruno, Seufferlein Thomas, Werner Jens, van Laethem Jean-Luc, Lordick Florian, Laurent-Puig Pierre, Huguet Florence, Zalcberg John R, Ducreux Michel, Aust Daniela, Bruno Marco J, Büchler Markus W, Delpero Jean-Robert, Gloor Beat, Glynne-Jones Rob, Hartwig Werner, Otto Florian
Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008
Worni M, Gueller U, White R, Castleberry A, Pietrobon R, Cerny T, Gloor B, Koeberle D. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008. Pancreas 2013; 42:1157-63.
Oct 1, 2013Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008
Oct 1, 2013Pancreas 2013; 42:1157-63
Worni Mathias, Gueller Ulrich, White Rebekah R, Castleberry Anthony W, Pietrobon Ricardo, Cerny Thomas, Gloor Beat, Koeberle Dieter
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Christ E, Reubi J, Perren A, Gloor B, Seufert J, Ell P, Stettler C, Fischli S, Clerici T, Brändle M, Caplin M, Nicolas G, Béhé M, Ederer S, Wild D, Forrer F. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013; 1:115-22.
Jul 25, 2013Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Jul 25, 2013Lancet Diabetes Endocrinol 2013; 1:115-22
Christ Emanuel, Reubi Jean Claude, Perren Aurel, Gloor Beat, Seufert Jochen, Ell Peter J, Stettler Christoph, Fischli Stefan, Clerici Thomas, Brändle Michael, Caplin Martyn E, Nicolas Guillaume, Béhé Martin, Ederer Susanne, Wild Damian, Forrer Flavio
Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Christ E, Maecke H, Martius F, Gloor B, Clerici T, Sahli R, Brändle M, Forrer F, Wild D, Reubi J. Glucagon-like peptide-1 receptor imaging for localization of insulinomas. The Journal of clinical endocrinology and metabolism 2009; 94:4398-405.
Nov 1, 2009Glucagon-like peptide-1 receptor imaging for localization of insulinomas
Nov 1, 2009The Journal of clinical endocrinology and metabolism 2009; 94:4398-405
Christ Emanuel, Maecke Helmut, Martius Ferdinand, Gloor Beat, Clerici Thomas, Sahli Rahel, Brändle Michael, Forrer Flavio, Wild Damian, Reubi Jean Claude